Ugrás a tartalomra
Merck

SAB4200637

Sigma-Aldrich

Monoclonal Anti-phospho-RNA polymerase II CTD (pSer2) antibody produced in rat

clone 3E7C7, purified from hybridoma cell culture

Szinonimák:

POLR2, POLRA, RPB1, RPBh1, RPO2, RPOL2, RpIILS, hRPB220, hsRPB1, polymerase (RNA) II (DNA directed) polypeptide A 220kDa (POLR2A)

Bejelentkezésa Szervezeti és Szerződéses árazás megtekintéséhez


About This Item

UNSPSC kód:
12352203
NACRES:
NA.41
klón:
3E7C7, monoclonal
application:
FACS
IF
faj reaktivitás:
rat, canine, mouse, human, monkey
technika/technikák:
flow cytometry: 10 μg/test using using HeLa cells.
immunoblotting: 0.25-0.5 μg/mL using whole extracts of HeLa cells.
immunofluorescence: 4-8 μg/mL using using A549 cells
citations:
5

biológiai forrás

rat

Minőségi szint

antitest forma

purified immunoglobulin

antitest terméktípus

primary antibodies

klón

3E7C7, monoclonal

molekulatömeg

~250 kDa

faj reaktivitás

rat, canine, mouse, human, monkey

koncentráció

~1 mg/mL

technika/technikák

flow cytometry: 10 μg/test using using HeLa cells.
immunoblotting: 0.25-0.5 μg/mL using whole extracts of HeLa cells.
immunofluorescence: 4-8 μg/mL using using A549 cells

izotípus

IgG2a

UniProt elérési szám

kiszállítva

dry ice

tárolási hőmérséklet

−20°C

célzott transzláció utáni módosítás

phosphorylation (pSer2)

Géninformáció

human ... POLR2A(5430)

Related Categories

Általános leírás

Monoclonal Anti-phospho-RNA polymerase II CTD (pSer2 ) (rat IgG2a isotype) is derived from the hybridoma 3E7C7 produced by the fusion of mouse myeloma cells and lymph node cells from rat immunized with a synthetic peptide containing phospho-Ser2 of human RNA Polymerase II CTD repeat. RNA polymerase II subunit A (RNAPII), also known as POLR2A, is the largest subunit of RNA polymerase II. The POLR2A gene is mapped to human chromosome 17p13.1. This polymerase contains a carboxy-terminal domain (CTD) composed of heptapeptide repeats. These repeats contain serine and threonine residues that are phosphorylated in actively transcribing RNA polymerase.

Egyediség

Monoclonal Anti-RNA polymerase II CTD (pSer2) recognizes specifically phospho-Ser2 RNAPII but not phosphor-Ser5 or phosphor-Ser7.

Immunogén

synthetic peptide containing phospho-Ser2 of human RNA Polymerase II CTD repeat.

Alkalmazás

Monoclonal Anti-phospho-RNA polymerase II CTD (pSer2) antibody produced in rat may be used in:
  • immunoblotting
  • immunofluorescence
  • flow cytometry

Biokémiai/fiziológiai hatások

RNA polymerase II subunit A (RNAPII) is responsible for synthesizing messenger RNA in eukaryotes. The carboxy-terminal domain (CTD) is essential for polymerase activity. The CTD mediates the coupling of transcription and processing of the nascent RNA. It also plays roles in transcription, elongation and termination. Also, this subunit, in combination with several other polymerase subunits, forms the DNA binding domain of the polymerase, a groove in which the DNA template is transcribed into RNA. CTD is being dynamically modified during the transcription cycle. The phosphorylation of serine is needed for RNA capping and splicing factors recruitment.

Fizikai forma

Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 15 mM sodium azide.

Tárolás és stabilitás

For extended storage, freeze at -20 0C in working aliquots. Repeated freezing and thawing or storage in “frost-free” freezers is not recommended. If slight turbidity occurs upon prolonged storage, clarify the solution by centrifugation before use. Working dilution samples should be discarded if not usedwithin 12 hours.

Jogi nyilatkozat

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Nem találja a megfelelő terméket?  

Próbálja ki a Termékválasztó eszköz. eszközt

Tárolási osztály kódja

10 - Combustible liquids

WGK

WGK 1

Lobbanási pont (F)

Not applicable

Lobbanási pont (C)

Not applicable


Válasszon a legfrissebb verziók közül:

Analitikai tanúsítványok (COA)

Lot/Batch Number

Nem találja a megfelelő verziót?

Ha egy adott verzióra van szüksége, a tétel- vagy cikkszám alapján rákereshet egy adott tanúsítványra.

Már rendelkezik ezzel a termékkel?

Az Ön által nemrégiben megvásárolt termékekre vonatkozó dokumentumokat a Dokumentumtárban találja.

Dokumentumtár megtekintése

Jing-Ping Hsin et al.
Genes & development, 26(19), 2119-2137 (2012-10-03)
The C-terminal domain (CTD) of the RNA polymerase II largest subunit consists of multiple heptad repeats (consensus Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7), varying in number from 26 in yeast to 52 in vertebrates. The CTD functions to help couple transcription and processing of the
Ballachanda N Devaiah et al.
Proceedings of the National Academy of Sciences of the United States of America, 109(18), 6927-6932 (2012-04-18)
The bromodomain protein, BRD4, has been identified recently as a therapeutic target in acute myeloid leukemia, multiple myeloma, Burkitt's lymphoma, NUT midline carcinoma, colon cancer, and inflammatory disease; its loss is a prognostic signature for metastatic breast cancer. BRD4 also
Jun Odawara et al.
BMC genomics, 12, 516-516 (2011-10-21)
Cellular function is regulated by the balance of stringently regulated amounts of mRNA. Previous reports revealed that RNA polymerase II (RNAPII), which transcribes mRNA, can be classified into the pausing state and the active transcription state according to the phosphorylation
Steven Hahn
Nature structural & molecular biology, 11(5), 394-403 (2004-04-29)
Advances in structure determination of the bacterial and eukaryotic transcription machinery have led to a marked increase in the understanding of the mechanism of transcription. Models for the specific assembly of the RNA polymerase II transcription machinery at a promoter
HDP101, a novel B-cell maturation antigen (BCMA)-targeted antibody conjugated to alpha-Amanitin, is active against myeloma with preferential efficacy against pre-clinical models of deletion 17p
Singh R K, et al.
Blood, 132(Supplement 1), 593-593 (2018)

Tudóscsoportunk valamennyi kutatási területen rendelkezik tapasztalattal, beleértve az élettudományt, az anyagtudományt, a kémiai szintézist, a kromatográfiát, az analitikát és még sok más területet.

Lépjen kapcsolatba a szaktanácsadással